1. ALLA AKTIER
  2. NYHETER
  3. BBS-BIOACTIVE BONE SUBSTITUTES

BBS-Bioactive Bone Substitutes

Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.
Datum Rubrik Källa
2025-03-05 13:30 BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North MARKN. MFN
2025-02-20 20:00 BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy MARKN. MFN
2025-02-17 12:15 BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt MARKN. MFN
2025-02-12 16:00 BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy MARKN. MFN
2025-02-10 08:00 BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations MARKN. MFN
2025-02-06 14:00 BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company MARKN. MFN
2025-01-31 15:30 BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors MARKN. MFN
2024-12-18 13:00 Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement MARKN. MFN
2024-12-18 12:00 BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement MARKN. MFN
2024-12-13 12:00 BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025 MARKN. MFN
2024-12-13 08:30 BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations MARKN. MFN
2024-11-29 15:30 BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans MARKN. MFN
2024-11-29 15:20 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-11-29 14:00 BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company MARKN. MFN
2024-11-26 16:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-11-22 18:05 BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself MARKN. MFN
2024-11-22 18:00 BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations MARKN. MFN
2024-11-14 13:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-11-07 12:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-11-05 18:00 BBS-Bioactive Bone Substitutes Plc – Insider information: The company updates the status of the CE marking process MARKN. MFN
2024-10-23 07:30 BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself MARKN. MFN
2024-09-24 16:00 BBS-Bioactive Bone Substitutes Plc’s rights issue raised gross proceeds of EUR 1.45 million MARKN. MFN
2024-09-23 16:00 BBS-Bioactive Bone Substitutes Oyj: Managers' Transactions - Oili Halonen MARKN. MFN
2024-09-23 16:00 BBS-Bioactive Bone Substitutes Oyj: Managers' Transactions - Jarmo Halonen MARKN. MFN
2024-09-20 13:00 BBS-Bioactive Bone Substitutes Oyj: Managers' Transactions - Pekka Jalovaara MARKN. MFN
2024-09-12 15:00 BBS-Bioactive Bone Substitutes Oyj: Managers' Transactions - Pekka Jalovaara MARKN. MFN
2024-09-11 14:00 BBS-Bioactive Bone Substitutes Plc: The complementary patent for the ARTEBONE® product has been granted in the USA MARKN. MFN
2024-08-30 17:30 BBS-Bioactive Bone Substitutes Plc has received subscription undertakings and supplements the Investor Memorandum relating to the rights offering and publishes updated Basic Information Document MARKN. MFN
2024-08-26 08:00 BBS-Bioactive Bone Substitutes Plc: BBS arranges a rights offering of approximately maximum EUR 2.4 million MARKN. MFN
2024-08-19 08:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-08-16 08:30 BBS-Bioactive Bone Substitutes Plc: ARTEBONE®’s CE process summary MARKN. MFN
2024-08-09 13:00 BBS-Bioactive Bone Substitutes Plc: Half Year Report, January-June, 2024 (unaudited) MARKN. MFN
2024-07-22 08:30 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-07-02 12:00 BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself MARKN. MFN
2024-06-19 15:00 BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Municipality of Reisjärvi MARKN. MFN
2024-06-18 14:00 BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Finha Capital Oy MARKN. MFN
2024-06-18 07:00 BBS-Bioactive Bone Substitutes Plc plans a share issue to strengthen its equity and will advance the publication date of its half-year report MARKN. MFN
2024-06-14 16:45 BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Panvest Oy MARKN. MFN
2024-06-13 17:00 BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2024 MARKN. MFN
2024-06-05 12:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-06-04 16:45 BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA MARKN. MFN
2024-05-23 16:00 Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting MARKN. MFN
2024-05-21 16:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-05-07 18:00 BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024 MARKN. MFN
2024-05-05 20:30 BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process MARKN. MFN
2024-04-25 16:00 BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc MARKN. MFN
2024-04-24 12:30 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-04-17 16:30 BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024 MARKN. MFN
2024-04-15 07:00 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd MARKN. MFN
2024-04-05 12:30 BBS-Bioactive Bone Substitutes Plc: The website's functionality restored MFN
Visa äldre nyheter